speb/financial-data huggingface dataset:
DuPont ROE decomposition for LXU (annual period ending 2023-12-31)
ROE: 5.399901760194314%
Net margin: 4.703145817226958%
Asset turnover: 0.4336803137176986
Equity multiplier (leverage): 2.6474496327610413
EBIT margin: 8.720939045896221%
Interest burden factor: 0.6546536106765553
Tax burden factor: 0.8237845173471796
ROE archetype: Standard Business
DuPont ROE decomposition for LXU (annual period ending 2024-12-31)
ROE: -3.832387266565079%
Net margin: -3.7046324655436447%
Asset turnover: 0.42037972585190464
Equity multiplier (leverage): 2.4608350140746618
EBIT margin: -1.0537901990811638%
ROE archetype: Low Return
DuPont ROE decomposition for LXU (annual period ending 2025-12-31)
ROE: 4.866090095718422%
Net margin: 4.000760718326159%
Asset turnover: 0.5212021550988318
Equity multiplier (leverage): 2.3336265943597008
EBIT margin: 9.309696883005422%
Interest burden factor: 0.568303244054894
Tax burden factor: 0.7561829856524009
ROE archetype: Low Return
DuPont ROE decomposition for LYG (annual period ending 2022-12-31)
ROE: 8.93398009610349%
Net margin: 24.442367601246108%
Asset turnover: 0.018376586053945872
Equity multiplier (leverage): 19.89009587574869
Tax burden factor: 0.8203680468423254
ROE archetype: Standard Business
DuPont ROE decomposition for LYG (annual period ending 2023-12-31)
ROE: 12.37777463074291%
Net margin: 28.74108026459712%
Asset turnover: 0.02241884203730724
Equity multiplier (leverage): 19.209953185453937
Tax burden factor: 0.7354391576702652
ROE archetype: Standard Business
DuPont ROE decomposition for LYG (annual period ending 2024-12-31)
ROE: 9.54049659363354%
Net margin: 24.066010858463688%
Asset turnover: 0.0206779537414613
Equity multiplier (leverage): 19.171642107091763
Tax burden factor: 0.7497906548316865
ROE archetype: Standard Business
DuPont ROE decomposition for LYG (annual period ending 2025-12-31)
ROE: 10.534427892206484%
Net margin: 23.751747553425208%
Asset turnover: 0.022468447182847216
Equity multiplier (leverage): 19.739780863083457
Tax burden factor: 0.7141570334784568
ROE archetype: Standard Business
DuPont ROE decomposition for LYTIX.OL (annual period ending 2022-12-31)
ROE: -41.522135165958204%
Net margin: -508.2857401867465%
Asset turnover: 0.07197150108632534
Equity multiplier (leverage): 1.1350400639838856
EBIT margin: -595.2769467863295%
ROE archetype: Low Return
DuPont ROE decomposition for LYTIX.OL (annual period ending 2023-12-31)
ROE: -92.30297998301346%
Net margin: -2202.3803558005516%
Asset turnover: 0.0359878762420052
Equity multiplier (leverage): 1.164574239764656
EBIT margin: -2425.0814332247555%
ROE archetype: Low Return
DuPont ROE decomposition for LYTIX.OL (annual period ending 2024-12-31)
ROE: -114.25345102071032%
Net margin: -846.7169675738795%
Asset turnover: 0.10231378743608341
Equity multiplier (leverage): 1.3188545512232879
EBIT margin: -861.3760891044642%
ROE archetype: Low Return
DuPont ROE decomposition for LYTIX.OL (annual period ending 2025-12-31)
ROE: -76.18999731758308%
Asset turnover: 0
Equity multiplier (leverage): 1.3432789603673334
ROE archetype: Low Return
DuPont ROE decomposition for LZM (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.4480678713331243
ROE archetype: Standard Business
DuPont ROE decomposition for LZM (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.8455416436678431
ROE archetype: Standard Business
DuPont ROE decomposition for M3M.AX (quarterly period ending 2024-12-31)
ROE: -48.31143213588297%
Equity multiplier (leverage): 1.0413287543840868
ROE archetype: Low Return
DuPont ROE decomposition for MADHAV.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.1380976523382342
ROE archetype: Standard Business
DuPont ROE decomposition for MADHAV.NS (quarterly period ending 2024-12-31)
Net margin: -4.739523274314323%
EBIT margin: 8.566757652279263%
Interest burden factor: -0.2974953143636054
ROE archetype: Standard Business
DuPont ROE decomposition for MADHAV.NS (quarterly period ending 2025-03-31)
ROE: 0.01505259762381216%
Net margin: 0.23202461025079515%
Asset turnover: 0.05516003481619487
Equity multiplier (leverage): 1.1761233413231902
EBIT margin: -21.84159758068721%
ROE archetype: Low Return
DuPont ROE decomposition for MADHAV.NS (quarterly period ending 2025-06-30)
Net margin: -2.200348866184899%
EBIT margin: -9.213805133316722%
ROE archetype: Standard Business
DuPont ROE decomposition for MADHAV.NS (quarterly period ending 2025-09-30)
ROE: -0.37340693930921%
Net margin: -6.392927595528604%
Asset turnover: 0.049362118946585626
Equity multiplier (leverage): 1.1832834888413204
EBIT margin: -20.29663184043253%
ROE archetype: Low Return
DuPont ROE decomposition for MADHAV.NS (quarterly period ending 2025-12-31)
Net margin: -7.386595986368799%
EBIT margin: -15.126088602801971%
ROE archetype: Standard Business
DuPont ROE decomposition for MADHAV.NS (quarterly period ending 2026-03-31)
ROE: 1.2628029126361593%
Net margin: 16.138843189886572%
Asset turnover: 0.06735485376024263
Equity multiplier (leverage): 1.1617007654223543
EBIT margin: -20.921724824660142%
Tax burden factor: 0.6021726839512156
ROE archetype: Low Return
DuPont ROE decomposition for MADHUCON.NS (annual period ending 2022-03-31)
Net margin: -11.216087701085453%
Asset turnover: 0.17228271275108764
EBIT margin: -21.556151735399087%
ROE archetype: Standard Business
DuPont ROE decomposition for MADHUCON.NS (annual period ending 2023-03-31)
Net margin: -12.782928791296733%
Asset turnover: 0.22330607592446186
EBIT margin: -63.691888530306116%
ROE archetype: Standard Business
DuPont ROE decomposition for MADHUCON.NS (annual period ending 2024-03-31)
Net margin: -3.898153633047701%
Asset turnover: 0.27600091684078093
EBIT margin: 6.4960414257502945%
Interest burden factor: -0.9424534111509982
ROE archetype: Standard Business
DuPont ROE decomposition for MADHUCON.NS (annual period ending 2025-03-31)
Net margin: -70.2382770046114%
Asset turnover: 0.17056494897685334
EBIT margin: -120.23114535223934%
ROE archetype: Standard Business
DuPont ROE decomposition for MADHUCON.NS (annual period ending 2026-03-31)
Net margin: -80.56359230057676%
Asset turnover: 0.15500607315841963
EBIT margin: -121.40822137871639%
ROE archetype: Standard Business
DuPont ROE decomposition for MAGH (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 1.784198338861725
ROE archetype: Standard Business
DuPont ROE decomposition for MAGH (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 2.698314443928141
ROE archetype: Standard Business
DuPont ROE decomposition for MAPS.V (quarterly period ending 2024-12-31)
Net margin: -269.0994001409643%
Asset turnover: 0.31800854631943887
EBIT margin: -297.5239968967563%
ROE archetype: Standard Business
DuPont ROE decomposition for MAPS.V (quarterly period ending 2025-03-31)
Net margin: -173.75340201272567%
Asset turnover: 0.5615997975998437
EBIT margin: -179.7755695462618%
ROE archetype: Standard Business
DuPont ROE decomposition for MAPS.V (quarterly period ending 2025-06-30)
Net margin: -128.95932062023732%
Asset turnover: 0.7508861940224226
EBIT margin: -130.38063464381847%
ROE archetype: Standard Business
DuPont ROE decomposition for MAPS.V (quarterly period ending 2025-09-30)
Net margin: -113.93116788760291%
Asset turnover: 0.4809847254665063
EBIT margin: -114.69288401645603%
ROE archetype: Standard Business
DuPont ROE decomposition for MAPS.V (quarterly period ending 2025-12-31)
Net margin: -84.33101360675441%
Asset turnover: 0.9374340527712326
EBIT margin: -88.68547178490347%
ROE archetype: Standard Business
DuPont ROE decomposition for MAPS.V (quarterly period ending 2026-03-31)
Net margin: -155.28226916873206%
Asset turnover: 0.6506062614222413
EBIT margin: -126.51677878752115%
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.AX (annual period ending 2021-06-30)
ROE: 9.195629857750403%
Net margin: 4.408254800712856%
Asset turnover: 0.6741014200513238
Equity multiplier (leverage): 3.0944933274673705
EBIT margin: 7.1591520234525765%
Interest burden factor: 0.8611479353856729
Tax burden factor: 0.7150350647129254
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.AX (annual period ending 2022-06-30)
ROE: 5.745209945358469%
Net margin: 2.733826905046717%
Asset turnover: 0.6632724113553866
Equity multiplier (leverage): 3.1684215390099504
EBIT margin: 7.024991109243155%
Interest burden factor: 0.6098762023102766
Tax burden factor: 0.6380923634168427
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.AX (annual period ending 2023-06-30)
ROE: 7.517125765741646%
Net margin: 5.126919588130794%
Asset turnover: 0.6676768500757106
Equity multiplier (leverage): 2.195983091826052
EBIT margin: 11.055146771150607%
Interest burden factor: 0.6677327181691878
Tax burden factor: 0.6945273241206029
ROE archetype: Standard Business
DuPont ROE decomposition for MAQ.AX (annual period ending 2024-06-30)
ROE: 8.548213111353904%
Net margin: 9.083827423519244%
Asset turnover: 0.591786210516985
Equity multiplier (leverage): 1.5901629293569317
EBIT margin: 14.053080975738657%
Interest burden factor: 0.9253339601206566
Tax burden factor: 0.6985521358113543
ROE archetype: Standard Business
DuPont ROE decomposition for MARICO.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.639225181598063
ROE archetype: Standard Business
DuPont ROE decomposition for MARICO.NS (quarterly period ending 2025-03-31)
ROE: 7.395705178391679%
Net margin: 12.637362637362637%
Asset turnover: 0.3282708142726441
Equity multiplier (leverage): 1.7827517429072066
EBIT margin: 14.871794871794872%
Interest burden factor: 1.0862068965517242
Tax burden factor: 0.7823129251700679
ROE archetype: Standard Business
DuPont ROE decomposition for MARICO.NS (quarterly period ending 2025-06-30)
Net margin: 15.74102485424977%
EBIT margin: 18.717397974838907%
Interest burden factor: 1.0754098360655737
Tax burden factor: 0.7820121951219513
ROE archetype: Standard Business
DuPont ROE decomposition for MARICO.NS (quarterly period ending 2025-09-30)
ROE: 10.271041369472181%
Net margin: 12.406662837449742%
Asset turnover: 0.40119829473441637
Equity multiplier (leverage): 2.063480741797432
EBIT margin: 14.732912119471568%
Interest burden factor: 1.0721247563352827
Tax burden factor: 0.7854545454545455
ROE archetype: Standard Business
DuPont ROE decomposition for MARICO.NS (quarterly period ending 2025-12-31)
Net margin: 13.005371783997738%
EBIT margin: 15.323720667232116%
Interest burden factor: 1.0461254612546125
Tax burden factor: 0.8112874779541446
ROE archetype: Standard Business
DuPont ROE decomposition for MARICO.NS (quarterly period ending 2026-03-31)
ROE: 9.078771695594124%
Net margin: 12.241224122412241%
Asset turnover: 0.330818858560794
Equity multiplier (leverage): 2.2418780596350687
EBIT margin: 13.83138313831383%
Interest burden factor: 1.0932754880694144
Tax burden factor: 0.8095238095238095
ROE archetype: Standard Business
DuPont ROE decomposition for MBG.DE (annual period ending 2022-12-31)
ROE: 17.112318003235494%
Net margin: 9.871547891238992%
Asset turnover: 0.5769551756629425
Equity multiplier (leverage): 3.0045643633002075
EBIT margin: 11.921315584233787%
Interest burden factor: 1.1353164840080516
Tax burden factor: 0.7293636721828212
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MBG.DE (annual period ending 2023-12-31)
ROE: 16.543194505472673%
Net margin: 9.535402585471488%
Asset turnover: 0.5953053748021472
Equity multiplier (leverage): 2.9143421570874
EBIT margin: 11.49812979854321%
Interest burden factor: 1.146216185366967
Tax burden factor: 0.7235112527384984
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MBG.DE (annual period ending 2024-12-31)
ROE: 10.807037604351745%
Net margin: 7.149333076912509%
Asset turnover: 0.5337348240398794
Equity multiplier (leverage): 2.8321457024141834
EBIT margin: 8.448837177356209%
Interest burden factor: 1.1500691000731647
Tax burden factor: 0.7357743691241959
ROE archetype: Standard Business
DuPont ROE decomposition for MBG.DE (annual period ending 2025-12-31)
ROE: 6.018914956787738%
Net margin: 4.032099475093409%
Asset turnover: 0.5395275629510756
Equity multiplier (leverage): 2.766771749759932
EBIT margin: 3.683422330464247%
Interest burden factor: 1.2903490759753595
Tax burden factor: 0.8483450031826861
ROE archetype: Standard Business
DuPont ROE decomposition for MBH.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.3896863529201111
ROE archetype: Standard Business
DuPont ROE decomposition for MBO.L (annual period ending 2021-12-31)
ROE: 31.472095575574947%
Net margin: 0.5961617751423337%
Asset turnover: 20.367013989916824
Equity multiplier (leverage): 2.591995083146357
EBIT margin: 0.838779828199644%
Interest burden factor: 0.9398616481282122
Tax burden factor: 0.7562270721562033
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MBO.L (annual period ending 2022-12-31)
ROE: 0.4610565687728715%
Net margin: 0.01020569364427584%
Asset turnover: 18.237350371255296
Equity multiplier (leverage): 2.477136534670744
EBIT margin: 0.2789212607912954%
Interest burden factor: 0.42787314937938165
Tax burden factor: 0.08551570374724889
ROE archetype: Low Return
DuPont ROE decomposition for MBO.L (annual period ending 2023-12-31)
ROE: -32.35849771358231%
Net margin: -0.5826577454238842%
Asset turnover: 16.926229795034825
Equity multiplier (leverage): 3.2810631859630064
EBIT margin: -0.2894097581521735%
ROE archetype: Low Return
DuPont ROE decomposition for MBO.L (annual period ending 2024-12-31)
ROE: -226.42534342798538%
Net margin: -1.4968106109629742%
Asset turnover: 14.27614414746868
Equity multiplier (leverage): 10.596129502702755
EBIT margin: -1.0551145573629417%
ROE archetype: Low Return
DuPont ROE decomposition for MBO.V (quarterly period ending 2024-10-31)
Net margin: -26767.41573033708%
Asset turnover: 0.0025197678416145927
EBIT margin: -19174.959871589086%
ROE archetype: Standard Business
DuPont ROE decomposition for MBO.V (quarterly period ending 2025-01-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MBO.V (quarterly period ending 2025-06-30)
Net margin: -261.1440722882221%
Asset turnover: 2.1308997802361214
EBIT margin: 6.137363134557958%
Interest burden factor: -42.54393724935126
ROE archetype: Standard Business
DuPont ROE decomposition for MBO.V (quarterly period ending 2025-12-31)
Net margin: -8.688793641367559%
Asset turnover: 0.628370837244394
EBIT margin: -7.542266328191884%
ROE archetype: Standard Business
DuPont ROE decomposition for MBO.V (quarterly period ending 2026-03-31)
Net margin: -21.017025791501435%
Asset turnover: 0.5138998957287718
EBIT margin: -16.63814308911459%
ROE archetype: Standard Business
DuPont ROE decomposition for MBRX (annual period ending 2022-12-31)
ROE: -55.61303673047077%
Asset turnover: 0
Equity multiplier (leverage): 1.100228008660497
ROE archetype: Low Return
DuPont ROE decomposition for MBRX (annual period ending 2023-12-31)
ROE: -76.07329040171726%
Asset turnover: 0
Equity multiplier (leverage): 1.2220050086885414
ROE archetype: Low Return
DuPont ROE decomposition for MBRX (annual period ending 2024-12-31)
ROE: -139.7387409136021%
Asset turnover: 0
Equity multiplier (leverage): 1.4790912260937206
ROE archetype: Low Return
DuPont ROE decomposition for MBRX (annual period ending 2025-12-31)
ROE: -256.04638742656596%
Asset turnover: 0
Equity multiplier (leverage): 1.48970016021973
ROE archetype: Low Return
DuPont ROE decomposition for MCE.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.754637839312508
ROE archetype: Standard Business
DuPont ROE decomposition for MCHA.DE (annual period ending 2022-12-31)
ROE: 11.73755550362234%
Net margin: 7.026932493878979%
Asset turnover: 0.8088609743676795
Equity multiplier (leverage): 2.065085300303809
EBIT margin: 10.947883875480938%
Interest burden factor: 0.8485623003194888
Tax burden factor: 0.7564006024096386
ROE archetype: Standard Business
DuPont ROE decomposition for MCHA.DE (annual period ending 2023-12-31)
ROE: 11.547310632951854%
Net margin: 6.996436509896624%
Asset turnover: 0.8210969462837487
Equity multiplier (leverage): 2.0100622829482
EBIT margin: 12.158204847757824%
Interest burden factor: 0.722576900754498
Tax burden factor: 0.7963855421686749
ROE archetype: Standard Business
DuPont ROE decomposition for MCHA.DE (annual period ending 2024-12-31)
ROE: 10.002857959416977%
Net margin: 6.950318096568969%
Asset turnover: 0.7261794552252092
Equity multiplier (leverage): 1.9818713635994762
EBIT margin: 11.719927922627148%
Interest burden factor: 0.767179165359272
Tax burden factor: 0.7730061349693251
ROE archetype: Standard Business
DuPont ROE decomposition for MCHA.DE (annual period ending 2025-12-31)
ROE: 9.631277066124042%
Net margin: 6.405817174515235%
Asset turnover: 0.7634591919283401
Equity multiplier (leverage): 1.9693527268432678
EBIT margin: 10.095413973530317%
Interest burden factor: 0.8605182926829269
Tax burden factor: 0.7373782108060231
ROE archetype: Standard Business
DuPont ROE decomposition for MCHB (annual period ending 2022-12-31)
Net margin: 31.164352197688228%
Tax burden factor: 0.7168408719309975
ROE archetype: Standard Business
DuPont ROE decomposition for MCHB (annual period ending 2023-12-31)
ROE: 9.031738612143021%
Net margin: 32.375030464731466%
Asset turnover: 0.03563474489330951
Equity multiplier (leverage): 7.828661592723223
Tax burden factor: 0.7264609163062797
ROE archetype: Standard Business
DuPont ROE decomposition for MCHB (annual period ending 2024-12-31)
ROE: 1.2782004432863843%
Net margin: 7.646508193911587%
Asset turnover: 0.022313840762155535
Equity multiplier (leverage): 7.491373943161755
Tax burden factor: 0.8123651847494188
ROE archetype: Low Return
DuPont ROE decomposition for MCHB (annual period ending 2025-12-31)
ROE: 10.291498676572733%
Net margin: 40.07144548172923%
Asset turnover: 0.03414705995406418
Equity multiplier (leverage): 7.5212547124525315
Tax burden factor: 0.8316038178688782
ROE archetype: Standard Business
DuPont ROE decomposition for MCHX (annual period ending 2022-12-31)
ROE: -18.691059122234314%
Net margin: -15.80410197431474%
Asset turnover: 0.9185829489030531
Equity multiplier (leverage): 1.2874954660863258
EBIT margin: -15.478244201648456%
ROE archetype: Low Return
DuPont ROE decomposition for MCHX (annual period ending 2023-12-31)
ROE: -24.78057562951664%
Net margin: -19.85574033259868%
Asset turnover: 0.957313155143808
Equity multiplier (leverage): 1.303680828186342
EBIT margin: -19.296734121418556%
ROE archetype: Low Return
DuPont ROE decomposition for MCHX (annual period ending 2024-12-31)
ROE: -14.443163073150082%
Net margin: -10.280121358214538%
Asset turnover: 1.0613937382136596
Equity multiplier (leverage): 1.323693852823964
EBIT margin: -9.241095548813433%
ROE archetype: Low Return
DuPont ROE decomposition for MCHX (annual period ending 2025-12-31)
ROE: -16.693772122835547%
Net margin: -11.525759577278732%
Asset turnover: 1.096042471042471
Equity multiplier (leverage): 1.3214707101629517
EBIT margin: -9.630118890356671%
ROE archetype: Low Return
DuPont ROE decomposition for MCI.V (quarterly period ending 2024-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MCI.V (quarterly period ending 2025-03-31)
Asset turnover: 0
Interest burden factor: 2.1376794258373204
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MCI.V (quarterly period ending 2025-06-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MCI.V (quarterly period ending 2025-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MCI.V (quarterly period ending 2025-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MCM.MC (annual period ending 2022-12-31)
ROE: 9.577614891111171%
Net margin: 9.382015973806041%
Asset turnover: 0.7479392557363668
Equity multiplier (leverage): 1.3648812713637368
EBIT margin: 12.47890573793586%
Interest burden factor: 0.975805684951041
Tax burden factor: 0.7704710409664377
ROE archetype: Standard Business
DuPont ROE decomposition for MCM.MC (annual period ending 2023-12-31)
ROE: 12.73112184546025%
Net margin: 13.809045031181402%
Asset turnover: 0.690192552800729
Equity multiplier (leverage): 1.3357733046836935
EBIT margin: 17.904170128572765%
Interest burden factor: 1.0211624925515972
Tax burden factor: 0.7552914964723357
ROE archetype: Standard Business
DuPont ROE decomposition for MCM.MC (annual period ending 2024-12-31)
ROE: 12.75592481655451%
Net margin: 15.75152828540932%
Asset turnover: 0.6124166247498694
Equity multiplier (leverage): 1.3223374014014868
EBIT margin: 19.461461331953295%
Interest burden factor: 1.0558260898469312
Tax burden factor: 0.7665753683415187
ROE archetype: Standard Business
DuPont ROE decomposition for MCM.MC (annual period ending 2025-12-31)
ROE: 12.056244173759524%
Net margin: 14.362686838239746%
Asset turnover: 0.6461893059783683
Equity multiplier (leverage): 1.2990222127024558
EBIT margin: 17.3619762873557%
Interest burden factor: 1.0625630861274753
Tax burden factor: 0.7785415731113337
ROE archetype: Standard Business
DuPont ROE decomposition for MCRB (annual period ending 2022-12-31)
ROE: -2319.9202448298247%
Asset turnover: 0
Equity multiplier (leverage): 32.345729388852824
ROE archetype: Low Return
DuPont ROE decomposition for MCRB (annual period ending 2023-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MCRB (annual period ending 2024-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MCRB (annual period ending 2025-12-31)
ROE: 19.640702044757077%
Net margin: 721.9264892268694%
Asset turnover: 0.005676197738873322
Equity multiplier (leverage): 4.792989896900107
EBIT margin: -11910.139416983524%
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MDI.AX (annual period ending 2021-06-30)
ROE: -123.36869718053217%
Equity multiplier (leverage): 1.3254850298231555
ROE archetype: Low Return
DuPont ROE decomposition for MDI.AX (annual period ending 2022-06-30)
ROE: 53.53534361017416%
Equity multiplier (leverage): 1.1387713077189665
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MDI.AX (annual period ending 2023-06-30)
ROE: -78.95506896213232%
Equity multiplier (leverage): 1.0193433727040349
ROE archetype: Low Return
DuPont ROE decomposition for MDI.AX (annual period ending 2024-06-30)
ROE: -21.0616224528622%
Equity multiplier (leverage): 1.0512716097024477
ROE archetype: Low Return
DuPont ROE decomposition for MDIA3.SA (annual period ending 2022-12-31)
ROE: 7.182278112325732%
Net margin: 4.75692811035022%
Asset turnover: 0.8854593368306914
Equity multiplier (leverage): 1.705167348589992
EBIT margin: 5.714249045211347%
Interest burden factor: 0.6076125416372959
Tax burden factor: 1.3700634932369609
ROE archetype: Standard Business
DuPont ROE decomposition for MDIA3.SA (annual period ending 2023-12-31)
ROE: 12.909857973680403%
Net margin: 8.197703380355488%
Asset turnover: 0.9488683999646322
Equity multiplier (leverage): 1.659675873491668
EBIT margin: 9.826987863782115%
Interest burden factor: 0.8786733541542873
Tax burden factor: 0.9493892804374233
ROE archetype: Standard Business
DuPont ROE decomposition for MDIA3.SA (annual period ending 2024-12-31)
ROE: 7.303779393687658%
Net margin: 6.68487181761291%
Asset turnover: 0.6782341930710432
Equity multiplier (leverage): 1.6109233707125574
EBIT margin: 8.901136964697622%
Interest burden factor: 0.9570783465216915
Tax burden factor: 0.7846935986442902
ROE archetype: Standard Business
DuPont ROE decomposition for MDIA3.SA (annual period ending 2025-12-31)
ROE: 8.608073841329944%
Net margin: 6.321570928344474%
Asset turnover: 0.8740970178243807
Equity multiplier (leverage): 1.5578345451098874
EBIT margin: 6.840533811197804%
Interest burden factor: 0.991997019541054
Tax burden factor: 0.9315896480155874
ROE archetype: Standard Business
DuPont ROE decomposition for MDLN (annual period ending 2025-12-31)
ROE: 6.009540599398528%
Net margin: 4.076392796848621%
Asset turnover: 0.7388005404843572
Equity multiplier (leverage): 1.9954371046354868
EBIT margin: 7.779966235227913%
Interest burden factor: 0.5641952983725136
Tax burden factor: 0.9286858974358975
ROE archetype: Standard Business
DuPont ROE decomposition for MDLZ (quarterly period ending 2025-03-31)
ROE: 1.5761143166944196%
Net margin: 4.370235155159455%
Asset turnover: 0.13511396114730076
Equity multiplier (leverage): 2.6692096193316037
EBIT margin: 7.323096746483411%
Interest burden factor: 0.7991202346041055
Tax burden factor: 0.7467889908256881
ROE archetype: Low Return
DuPont ROE decomposition for MDLZ (quarterly period ending 2025-06-30)
ROE: 2.4735932398694067%
Net margin: 7.168299198575245%
Asset turnover: 0.1283914624822254
Equity multiplier (leverage): 2.68767044363357
EBIT margin: 13.067675868210152%
Interest burden factor: 0.7282793867120954
Tax burden factor: 0.7532163742690059
ROE archetype: Low Return
DuPont ROE decomposition for MDLZ (quarterly period ending 2025-09-30)
ROE: 2.8432045125390655%
Net margin: 7.655993431855501%
Asset turnover: 0.13687507901501636
Equity multiplier (leverage): 2.713202225779404
EBIT margin: 8.05623973727422%
Interest burden factor: 0.8853503184713376
Tax burden factor: 1.0733812949640287
ROE archetype: Low Return
DuPont ROE decomposition for MDLZ (quarterly period ending 2025-12-31)
ROE: 2.5671527244819647%
Net margin: 6.373856707317073%
Asset turnover: 0.14695649130176064
Equity multiplier (leverage): 2.7406945510360705
EBIT margin: 9.32736280487805%
Interest burden factor: 0.9387129724208376
Tax burden factor: 0.7279651795429815
ROE archetype: Low Return
DuPont ROE decomposition for MDLZ (quarterly period ending 2026-03-31)
ROE: 2.182029209788181%
Net margin: 5.595238095238096%
Asset turnover: 0.14136555196376105
Equity multiplier (leverage): 2.7586613792436405
EBIT margin: 8.531746031746032%
Interest burden factor: 0.9011627906976745
Tax burden factor: 0.727741935483871
ROE archetype: Low Return
DuPont ROE decomposition for MDNA.TO (quarterly period ending 2024-12-31)
ROE: -29.746146352644548%
Asset turnover: 0
Equity multiplier (leverage): 1.8474012950547247
ROE archetype: Low Return
DuPont ROE decomposition for MDNA.TO (quarterly period ending 2025-03-31)
ROE: 6.495922946423686%
Asset turnover: 0
Equity multiplier (leverage): 1.658758824495157
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MDNA.TO (quarterly period ending 2025-06-30)
ROE: -29.92578261188981%
Asset turnover: 0
Equity multiplier (leverage): 1.5169707992775727
ROE archetype: Low Return
DuPont ROE decomposition for MDNA.TO (quarterly period ending 2025-09-30)
ROE: -38.91342492829934%
Asset turnover: 0
Equity multiplier (leverage): 1.6393927381143854
ROE archetype: Low Return
DuPont ROE decomposition for MDNA.TO (quarterly period ending 2025-12-31)
ROE: -53.52423121279155%
Asset turnover: 0
Equity multiplier (leverage): 1.8916484530724575
ROE archetype: Low Return
DuPont ROE decomposition for MDNA.TO (quarterly period ending 2026-03-31)
ROE: -96.3950205317482%
Asset turnover: 0
Equity multiplier (leverage): 2.471315377955334
ROE archetype: Low Return
DuPont ROE decomposition for MEDCL.PA (annual period ending 2022-03-31)
Net margin: -606.5036674816625%
Asset turnover: 0.09231880459562558
EBIT margin: -582.2982885085574%
ROE archetype: Standard Business
DuPont ROE decomposition for MEDCL.PA (annual period ending 2023-03-31)
Net margin: -321.9026548672566%
Asset turnover: 0.26650046617332596
EBIT margin: -241.80410297666936%
ROE archetype: Standard Business
DuPont ROE decomposition for MEDCL.PA (annual period ending 2024-03-31)
Net margin: -273.3406113537118%
Asset turnover: 0.2750506997437719
EBIT margin: -228.98471615720527%
ROE archetype: Standard Business
DuPont ROE decomposition for MEDCL.PA (annual period ending 2025-03-31)
Net margin: -72.18981245840021%
Asset turnover: 0.4022118908308788
EBIT margin: -42.44156454328335%
ROE archetype: Standard Business
DuPont ROE decomposition for MEDX.SW (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.136109245578688
ROE archetype: Standard Business
DuPont ROE decomposition for MEDX.SW (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.176254162638307
ROE archetype: Standard Business
DuPont ROE decomposition for MEDX.SW (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.211527476626798
ROE archetype: Standard Business
DuPont ROE decomposition for MEDX.SW (quarterly period ending 2026-06-30)
Equity multiplier (leverage): 2.2258823359519413
ROE archetype: Standard Business
DuPont ROE decomposition for MEESHO.NS (quarterly period ending 2024-12-31)
Net margin: -1.3974623699107123%
EBIT margin: -5.3209071316387675%
Tax burden factor: -2.4225342997670207
ROE archetype: Standard Business
DuPont ROE decomposition for MEESHO.NS (quarterly period ending 2025-03-31)
ROE: -96.25483736625905%
Net margin: -57.97481223762747%
Asset turnover: 0.33212650221343865
Equity multiplier (leverage): 4.998960234324306
EBIT margin: -9.806852154709944%
ROE archetype: Low Return
DuPont ROE decomposition for MEESHO.NS (quarterly period ending 2025-06-30)
Net margin: -11.55644910710078%
EBIT margin: -10.876500579503857%
ROE archetype: Standard Business
DuPont ROE decomposition for MEESHO.NS (quarterly period ending 2025-09-30)
ROE: -48.37344070443469%
Net margin: -13.383340837929358%
Asset turnover: 0.46287536210233493
Equity multiplier (leverage): 7.8086934843553015
EBIT margin: -13.15703171971505%
ROE archetype: Low Return
DuPont ROE decomposition for MEESHO.NS (quarterly period ending 2025-12-31)
Net margin: -13.949149391147026%
EBIT margin: -15.630182869105566%
ROE archetype: Standard Business
DuPont ROE decomposition for MEESHO.NS (quarterly period ending 2026-03-31)
ROE: -3.792314012582608%
Net margin: -4.710705559450975%
Asset turnover: 0.4466074918809837
Equity multiplier (leverage): 1.8025707805904285
EBIT margin: -7.7445647556702895%
ROE archetype: Low Return
DuPont ROE decomposition for MEESHO.NS (quarterly period ending 2026-06-30)
Net margin: -3.5777474264108786%
EBIT margin: -6.579947107461168%
ROE archetype: Standard Business
DuPont ROE decomposition for MEK.V (quarterly period ending 2025-03-31)
ROE: -23.667060243665937%
Asset turnover: 0
Equity multiplier (leverage): 1.8269008779625464
ROE archetype: Low Return
DuPont ROE decomposition for MEK.V (quarterly period ending 2025-06-30)
ROE: -82.57649109732043%
Asset turnover: 0
Equity multiplier (leverage): 1.9370347220061368
ROE archetype: Low Return
DuPont ROE decomposition for MEK.V (quarterly period ending 2025-09-30)
ROE: -37.347913390287005%
Asset turnover: 0
Equity multiplier (leverage): 2.053068444186943
ROE archetype: Low Return
DuPont ROE decomposition for MEK.V (quarterly period ending 2025-12-31)
ROE: -30.570581423224652%
Asset turnover: 0
Equity multiplier (leverage): 1.5219852182893059
ROE archetype: Low Return
DuPont ROE decomposition for MEK.V (quarterly period ending 2026-03-31)
ROE: 20.12645972871091%
Asset turnover: 0
Equity multiplier (leverage): 1.3673933142827466
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MEMS.PA (annual period ending 2022-12-31)
ROE: 6.723551677680117%
Net margin: 11.225364181662382%
Asset turnover: 0.398191589183656
Equity multiplier (leverage): 1.50420221979855
EBIT margin: 2.5278491859468724%
Interest burden factor: 1.0296610169491527
Tax burden factor: 4.31275720164609
ROE archetype: Standard Business
DuPont ROE decomposition for MEMS.PA (annual period ending 2023-12-31)
ROE: 13.128945748789148%
Net margin: 15.206423648120513%
Asset turnover: 0.5775872758614065
Equity multiplier (leverage): 1.494807096000684
EBIT margin: 17.60108008242734%
Interest burden factor: 0.8772708922083166
Tax burden factor: 0.9848136217211227
ROE archetype: Standard Business
DuPont ROE decomposition for MEMS.PA (annual period ending 2024-12-31)
ROE: 7.402139832562951%
Net margin: 10.85308056872038%
Asset turnover: 0.4700803394282051
Equity multiplier (leverage): 1.4508822589276413
EBIT margin: 9.257503949447079%
Interest burden factor: 1.1928327645051193
Tax burden factor: 0.9828326180257511
ROE archetype: Standard Business
DuPont ROE decomposition for MEMS.PA (annual period ending 2025-12-31)
ROE: 5.077300696247575%
Net margin: 7.458079586218404%
Asset turnover: 0.4969587644782309
Equity multiplier (leverage): 1.3698894369026007
EBIT margin: 8.350713272712104%
Interest burden factor: 0.8951048951048952
Tax burden factor: 0.9977678571428571
ROE archetype: Standard Business
DuPont ROE decomposition for MER.TO (annual period ending 2022-12-31)
ROE: -7.259812183963402%
Asset turnover: 0
Equity multiplier (leverage): 1.1048639537683602
ROE archetype: Low Return
DuPont ROE decomposition for MER.TO (annual period ending 2023-12-31)
ROE: 10.242416067457311%
Asset turnover: 0
Equity multiplier (leverage): 1.0918044069989035
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MER.TO (annual period ending 2024-12-31)
ROE: -36.77327975229751%
Asset turnover: 0
Equity multiplier (leverage): 1.094842825301668
ROE archetype: Low Return
DuPont ROE decomposition for MER.TO (annual period ending 2025-12-31)
ROE: -4.892877619047877%
Net margin: -5.621775484789183%
Asset turnover: 0.4423742054643853
Equity multiplier (leverage): 1.967438022882443
EBIT margin: -0.07116171499733144%
Tax burden factor: -2.6779661016949152
ROE archetype: Low Return
DuPont ROE decomposition for MET.V (annual period ending 2022-03-31)
ROE: 19.407849120939368%
Net margin: 214.5255000061313%
Asset turnover: 0.0706789640616245
Equity multiplier (leverage): 1.2799951054209349
EBIT margin: 12.663306723564972%
Interest burden factor: 23.030832397257623
Tax burden factor: 0.7355668724677802
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MET.V (annual period ending 2023-03-31)
ROE: -20.74362320139794%
Net margin: -163.90617748323098%
Asset turnover: 0.09802120324669349
Equity multiplier (leverage): 1.2911278933591275
EBIT margin: 10.497043066731536%
Interest burden factor: -22.125682768436974
ROE archetype: Low Return
DuPont ROE decomposition for MET.V (annual period ending 2024-03-31)
ROE: -12.791401130450733%
Net margin: -199.45902471473636%
Asset turnover: 0.05177929481084919
Equity multiplier (leverage): 1.2385350338353365
EBIT margin: -84.56992001260885%
ROE archetype: Low Return
DuPont ROE decomposition for MET.V (annual period ending 2025-03-31)
ROE: 15.637920548351076%
Net margin: 240.323678306265%
Asset turnover: 0.05666233612669673
Equity multiplier (leverage): 1.1483861965827051
EBIT margin: -52.33692048982028%
Tax burden factor: 0.9175655479998023
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MET.V (annual period ending 2026-03-31)
ROE: -5.335472592118791%
Net margin: -47.39076907615385%
Asset turnover: 0.09882607237838106
Equity multiplier (leverage): 1.1392200006084845
EBIT margin: -0.8614105173236852%
ROE archetype: Low Return
DuPont ROE decomposition for METC (quarterly period ending 2025-03-31)
ROE: -2.6620839526190156%
Net margin: -7.023081036121673%
Asset turnover: 0.196367401401416
Equity multiplier (leverage): 1.9302993964779533
EBIT margin: -8.927934885931558%
ROE archetype: Low Return
DuPont ROE decomposition for METC (quarterly period ending 2025-06-30)
ROE: -3.977304262068318%
Net margin: -9.135781483927065%
Asset turnover: 0.22487670733419535
Equity multiplier (leverage): 1.9359700691773152
EBIT margin: -9.050791388542027%
ROE archetype: Low Return
DuPont ROE decomposition for METC (quarterly period ending 2025-09-30)
ROE: -3.044086413808642%
Net margin: -10.998710701180205%
Asset turnover: 0.15875604621396955
Equity multiplier (leverage): 1.7433513543188033
EBIT margin: -11.968990710436708%
ROE archetype: Low Return
DuPont ROE decomposition for METC (quarterly period ending 2025-12-31)
ROE: -2.910503741793488%
Net margin: -11.487653018975525%
Asset turnover: 0.12863577165183415
Equity multiplier (leverage): 1.9695866708627006
EBIT margin: -12.192301983485278%
ROE archetype: Low Return
DuPont ROE decomposition for METC (quarterly period ending 2026-03-31)
ROE: -3.979925480952019%
Net margin: -15.063356713509247%
Asset turnover: 0.10896455760056305
Equity multiplier (leverage): 2.4247553146420153
EBIT margin: -19.985527862975175%
ROE archetype: Low Return
DuPont ROE decomposition for METROBRAND.NS (annual period ending 2023-03-31)
ROE: 23.212334510710747%
Net margin: 17.183179398431182%
Asset turnover: 0.7316480695850838
Equity multiplier (leverage): 1.8463458948491855
EBIT margin: 23.473505013073495%
Interest burden factor: 0.9798457377541822
Tax burden factor: 0.7470813142775359
ROE archetype: Balanced Compounder
DuPont ROE decomposition for METROBRAND.NS (annual period ending 2024-03-31)
ROE: 23.795781831226602%
Net margin: 17.635373468200978%
Asset turnover: 0.7473420924464476
Equity multiplier (leverage): 1.8054932685947591
EBIT margin: 20.15331785439897%
Interest burden factor: 0.9802228353587903
Tax burden factor: 0.8927159432746025
ROE archetype: Balanced Compounder
DuPont ROE decomposition for METROBRAND.NS (annual period ending 2025-03-31)
ROE: 19.264554213894368%
Net margin: 14.136612174412438%
Asset turnover: 0.7403451547862671
Equity multiplier (leverage): 1.8406846119384732
EBIT margin: 19.91752379964824%
Interest burden factor: 1.0083298291984542
Tax burden factor: 0.7038941954445261
ROE archetype: Balanced Compounder
DuPont ROE decomposition for METROBRAND.NS (annual period ending 2026-03-31)
ROE: 21.070996586872937%
Net margin: 14.509905260106926%
Asset turnover: 0.7444222215963198
Equity multiplier (leverage): 1.9507480042230532
EBIT margin: 19.43093206873793%
Interest burden factor: 0.9906906529123161
Tax burden factor: 0.7537596371882085
ROE archetype: Balanced Compounder
DuPont ROE decomposition for METROGLOBL.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.03228420877486
ROE archetype: Standard Business
DuPont ROE decomposition for METROGLOBL.NS (quarterly period ending 2025-03-31)
ROE: -0.9319208000465941%
Net margin: -8.742671398597865%
Asset turnover: 0.10376364752827477
Equity multiplier (leverage): 1.0272818616006196
EBIT margin: 11.442489130484686%
Interest burden factor: -1.1014725354090598
ROE archetype: Low Return
DuPont ROE decomposition for METROGLOBL.NS (quarterly period ending 2025-06-30)
Net margin: 6.137555004053744%
EBIT margin: 4.801211791136225%
Interest burden factor: 1.8084173890625503
Tax burden factor: 0.706880268011476
ROE archetype: Standard Business
DuPont ROE decomposition for METROGLOBL.NS (quarterly period ending 2025-09-30)
ROE: 1.2585305153328115%
Net margin: 7.421316037103698%
Asset turnover: 0.16402144165058827
Equity multiplier (leverage): 1.0339087220807834
EBIT margin: 5.77709825101917%
Interest burden factor: 1.112022948366176
Tax burden factor: 1.1552006460151185
ROE archetype: Low Return
DuPont ROE decomposition for METROGLOBL.NS (quarterly period ending 2025-12-31)
Net margin: 9.088947657179492%
EBIT margin: 7.214321380356186%
Interest burden factor: 2.082072972742032
Tax burden factor: 0.6050930580920526
ROE archetype: Standard Business
DuPont ROE decomposition for METROGLOBL.NS (quarterly period ending 2026-03-31)
ROE: 2.0628306847621096%
Net margin: 22.985456375930234%
Asset turnover: 0.08609001438757244
Equity multiplier (leverage): 1.0424558515162385
EBIT margin: 17.43357413983103%
Interest burden factor: 1.7505267593763167
Tax burden factor: 0.7531785516860144
ROE archetype: Low Return
DuPont ROE decomposition for METROPOLIS.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.3737794680033886
ROE archetype: Standard Business
DuPont ROE decomposition for METROPOLIS.NS (quarterly period ending 2024-12-31)
Net margin: 9.751480477892128%
EBIT margin: 13.728957757196047%
Interest burden factor: 0.9553851500476163
Tax burden factor: 0.7434546811666777
ROE archetype: Standard Business
DuPont ROE decomposition for METROPOLIS.NS (quarterly period ending 2025-03-31)
ROE: 2.1902024157540105%
Net margin: 8.4656876870702%
Asset turnover: 0.18491086948162955
Equity multiplier (leverage): 1.3991348373403087
EBIT margin: 9.751673585941154%
Interest burden factor: 1.0704657026523758
Tax burden factor: 0.8109803464615863
ROE archetype: Low Return
DuPont ROE decomposition for METROPOLIS.NS (quarterly period ending 2025-06-30)
Net margin: 11.719661444032997%
EBIT margin: 15.259781300056572%
Interest burden factor: 1.039346555224367
Tax burden factor: 0.7389352347853354
ROE archetype: Standard Business
DuPont ROE decomposition for METROPOLIS.NS (quarterly period ending 2025-12-31)
Net margin: 10.368586904919987%
EBIT margin: 15.512908412880993%
Interest burden factor: 0.9077076755960132
Tax burden factor: 0.7363432936355891
ROE archetype: Standard Business
DuPont ROE decomposition for METROPOLIS.NS (quarterly period ending 2026-03-31)
ROE: 3.342581933744601%
Net margin: 11.999460301552975%
Asset turnover: 0.1986299133801354
Equity multiplier (leverage): 1.4024122448845728
EBIT margin: 16.348035799055104%
Interest burden factor: 1.0048324069419579
Tax burden factor: 0.7304701946315074
ROE archetype: Low Return
DuPont ROE decomposition for MFG.V (annual period ending 2022-12-31)
ROE: -94.43886798537058%
Asset turnover: 0
Equity multiplier (leverage): 1.1298271169889649
ROE archetype: Low Return
DuPont ROE decomposition for MFG.V (annual period ending 2023-12-31)
ROE: -71.38685869309803%
Asset turnover: 0
Equity multiplier (leverage): 1.111423604568844
ROE archetype: Low Return
DuPont ROE decomposition for MFG.V (annual period ending 2024-12-31)
ROE: -48.92187518543605%
Asset turnover: 0
Equity multiplier (leverage): 1.067667418532248
ROE archetype: Low Return
DuPont ROE decomposition for MFG.V (annual period ending 2025-12-31)
ROE: -26.611776623979143%
Asset turnover: 0
Equity multiplier (leverage): 1.0251978384993066
ROE archetype: Low Return
DuPont ROE decomposition for MGNS.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.292027194066749
ROE archetype: Standard Business
DuPont ROE decomposition for MGNS.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.3075729372885236
ROE archetype: Standard Business
DuPont ROE decomposition for MGNS.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.2942635513911664
ROE archetype: Standard Business
DuPont ROE decomposition for MGYR (quarterly period ending 2025-03-31)
ROE: 2.345787032986263%
Net margin: 29.319772528433948%
Asset turnover: 0.008948361962415705
Equity multiplier (leverage): 8.940965963776359
Tax burden factor: 0.710010593220339
ROE archetype: Low Return
DuPont ROE decomposition for MGYR (quarterly period ending 2025-06-30)
ROE: 2.1421168797942873%
Net margin: 28.023598820058996%
Asset turnover: 0.008772981923018924
Equity multiplier (leverage): 8.713086426177188
Tax burden factor: 0.7109959700633276
ROE archetype: Low Return
DuPont ROE decomposition for MGYR (quarterly period ending 2025-09-30)
ROE: 2.1474284013352327%
Net margin: 27.294346557128957%
Asset turnover: 0.009320211893521288
Equity multiplier (leverage): 8.441511279314524
Tax burden factor: 0.6880108991825613
ROE archetype: Low Return
DuPont ROE decomposition for MGYR (quarterly period ending 2025-12-31)
ROE: 2.6069246435845215%
Net margin: 32.48058001035733%
Asset turnover: 0.00945105566970347
Equity multiplier (leverage): 8.49228147470801
Tax burden factor: 0.7332242225859247
ROE archetype: Low Return
DuPont ROE decomposition for MGYR (quarterly period ending 2026-03-31)
ROE: 2.464376341987117%
Net margin: 30.032708890871245%
Asset turnover: 0.009545408099546997
Equity multiplier (leverage): 8.596427874292408
Tax burden factor: 0.7099343955014058
ROE archetype: Low Return
DuPont ROE decomposition for MHC.AX (annual period ending 2021-06-30)
ROE: -7.446773199622428%
Equity multiplier (leverage): 1.0100043249514141
ROE archetype: Low Return
DuPont ROE decomposition for MHC.AX (annual period ending 2022-06-30)
ROE: -6.585953712228345%
Equity multiplier (leverage): 1.0243534163289492
ROE archetype: Low Return
DuPont ROE decomposition for MHC.AX (annual period ending 2023-06-30)
ROE: -6.9515818567995105%
Equity multiplier (leverage): 1.0197258466662222
ROE archetype: Low Return
DuPont ROE decomposition for MHC.AX (annual period ending 2024-06-30)
ROE: -12.455801243788814%
Equity multiplier (leverage): 1.0128785299754406
ROE archetype: Low Return
DuPont ROE decomposition for MHK (quarterly period ending 2025-03-31)
ROE: 0.9234408985105382%
Net margin: 2.87433684377227%
Asset turnover: 0.1883730469478316
Equity multiplier (leverage): 1.7055037586334092
EBIT margin: 3.8007759917649855%
Interest burden factor: 0.9385416666666667
Tax burden factor: 0.8057713651498335
ROE archetype: Low Return
DuPont ROE decomposition for MHK (quarterly period ending 2025-06-30)
ROE: 1.8131749125901173%
Net margin: 5.228221690874701%
Asset turnover: 0.20613301063364145
Equity multiplier (leverage): 1.6824344812648906
EBIT margin: 6.73423503800721%
Interest burden factor: 0.9565447800741919
Tax burden factor: 0.8116343490304709
ROE archetype: Low Return
DuPont ROE decomposition for MHK (quarterly period ending 2025-09-30)
ROE: 1.3078023391391103%
Net margin: 3.945030639254505%
Asset turnover: 0.20131171234301606
Equity multiplier (leverage): 1.6467310951642566
EBIT margin: 4.956669930019218%
Interest burden factor: 0.9663496708119971
Tax burden factor: 0.8236184708554126
ROE archetype: Low Return
DuPont ROE decomposition for MHK (quarterly period ending 2025-12-31)
ROE: 0.5024013588760564%
Net margin: 1.555728414268252%
Asset turnover: 0.19772372728670928
Equity multiplier (leverage): 1.633270931894711
EBIT margin: 3.267029669963329%
Interest burden factor: 0.7482993197278912
Tax burden factor: 0.6363636363636364
ROE archetype: Low Return
DuPont ROE decomposition for MHK (quarterly period ending 2026-03-31)
ROE: 1.397508115333206%
Net margin: 4.291420823102577%
Asset turnover: 0.19860690578781878
Equity multiplier (leverage): 1.6396792056520908
EBIT margin: 4.097189137684612%
Interest burden factor: 0.9677996422182469
Tax burden factor: 1.0822550831792976
ROE archetype: Low Return
DuPont ROE decomposition for MICC.AS (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.97108175651553
ROE archetype: Standard Business
DuPont ROE decomposition for MICC.AS (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 5.073581450644494
ROE archetype: Standard Business
DuPont ROE decomposition for MICC.AS (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 20.74214659685861
ROE archetype: Standard Business
DuPont ROE decomposition for MIDW.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.439858527971917
ROE archetype: Standard Business
DuPont ROE decomposition for MIDW.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.566305261816518
ROE archetype: Standard Business
DuPont ROE decomposition for MIDW.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.792261475696196
ROE archetype: Standard Business
DuPont ROE decomposition for MII.L (annual period ending 2023-01-31)
ROE: -10.688416751611065%
Asset turnover: 0
Equity multiplier (leverage): 1.0367499697655536
ROE archetype: Low Return
DuPont ROE decomposition for MII.L (annual period ending 2024-01-31)
ROE: -23.70727968399192%
Asset turnover: 0
Equity multiplier (leverage): 1.0590907322056335
ROE archetype: Low Return
DuPont ROE decomposition for MII.L (annual period ending 2025-01-31)
ROE: -68.89780274041124%
Asset turnover: 0
Equity multiplier (leverage): 1.1147895503029064
ROE archetype: Low Return
DuPont ROE decomposition for MIKN.SW (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.8339836496270043
ROE archetype: Standard Business
DuPont ROE decomposition for MIKN.SW (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.6020960551059649
ROE archetype: Standard Business
DuPont ROE decomposition for MILA.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0322593614793572
ROE archetype: Standard Business
DuPont ROE decomposition for MILA.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0235290353813533
ROE archetype: Standard Business
DuPont ROE decomposition for MINDTECK.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.2222040214587002
ROE archetype: Standard Business